[American judge preserves confidentiality in the peer review process].
Pharmaceutical concern Pfizer subpoenaed various medical journals, including JAMA and Annals of Internal Medicine, to hand over confidential documents relating to studies on its cyclo-oxygenase-2 inhibitors celecoxib and valdecoxib. Pfizer wanted this information to help defend 3000 product liability lawsuits over alleged side effects of the 2 drugs. However, a federal judge in Chicago rejected the company's bid, thereby preserving the confidentiality of the peer review process. It is unlikely that subpoenas like this will take place in the Netherlands.
Overbeke
A J P M
AJ
Universitair Medisch Centrum St Radboud, afd. Medische Informatiekunde, Nijmegen. a.overbeke@mi.umcn.nl
D003219:Confidentiality / Q000331:legislation & jurisprudence*; D005104:Expert Testimony; D006801:Humans; D017712:Peer Review, Research / Q000331:legislation & jurisprudence*; D010506:Periodicals as Topic; D014481:United States